These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9589563)

  • 41. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
    Campbell SB; Komata T; Kelso A
    Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
    Koulova L; Clark EA; Shu G; Dupont B
    J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of anti-CD3-treated lymphocytes as stimulator cells in human autologous mixed lymphocyte cultures for generation of autorestricted CD8+ suppressor T cells.
    Balashov KE; Brondz BD
    Immunol Lett; 1992 Feb; 31(3):233-6. PubMed ID: 1347753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of human T cell proliferation by a monoclonal antibody to CD5.
    Spertini F; Stohl W; Ramesh N; Moody C; Geha RS
    J Immunol; 1991 Jan; 146(1):47-52. PubMed ID: 1701800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a porcine CD1-specific mAb that distinguishes CD4/CD8 double-positive thymic from peripheral T lymphocytes.
    Pescovitz MD; Hsu SM; Katz SI; Lunney JK; Shimada S; Sachs DH
    Tissue Antigens; 1990 Apr; 35(4):151-6. PubMed ID: 1695393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotype analysis of lymphocyte subsets in normal human bone marrow.
    Clark P; Normansell DE
    Am J Clin Pathol; 1990 Nov; 94(5):632-6. PubMed ID: 1700596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of porcine T lymphocytes and their immune response against viral antigens.
    Saalmüller A; Pauly T; Höhlich BJ; Pfaff E
    J Biotechnol; 1999 Aug; 73(2-3):223-33. PubMed ID: 10486931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
    de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA
    Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative assessment of the roles of CD8 and CD2 in the functions of activated murine CD8+ T lymphocytes.
    Reimann A; Ehrfeld A; Kupsch J; Maier B; Saizawa KM; Clinchy B; Eichmann K
    Immunol Lett; 1991 Oct; 30(2):149-58. PubMed ID: 1684570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the porcine gammadelta T-cell receptor structure and cellular distribution by monoclonal antibody PPT27.
    Yang H; Parkhouse RM
    Immunology; 2000 Apr; 99(4):504-9. PubMed ID: 10792497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes.
    Biselli R; Matricardi PM; D'Amelio R; Fattorossi A
    Scand J Immunol; 1992 Apr; 35(4):439-47. PubMed ID: 1373002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Some combinations of anti-CD2 MAb induce apoptosis of activated CD8+/CD57+ T cells.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    Transplant Proc; 1995 Feb; 27(1):1431-3. PubMed ID: 7533385
    [No Abstract]   [Full Text] [Related]  

  • 53. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
    Panzer S; Geller RL; Bach FH
    Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants.
    Geppert TD; Lipsky PE
    J Clin Invest; 1988 May; 81(5):1497-505. PubMed ID: 2452835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential immunomodulation by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell activation: dependence upon the individual anti-CD3 monoclonal antibody used for activation.
    Stohl W; Posnett DN; Chiorazzi N
    Cell Immunol; 1988 Oct; 116(1):73-85. PubMed ID: 2458845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human thymocytes do not respond to interleukin-2 after removal of mature "bright" CD5 positive cells.
    Ueno Y; Hays EF; Hultin L; Uittenbogaart CH
    Cell Immunol; 1989 Dec; 124(2):239-51. PubMed ID: 2479484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes.
    Feito MJ; Ballester S; Díez-Orejas R; Ojeda G; Criado G; Portolés P; Rojo JM
    Scand J Immunol; 1997 Feb; 45(2):166-74. PubMed ID: 9042429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
    Finck BK; Yung CM; Carteron NL; Wofsy D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.